Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 144.40
Bid: 144.00
Ask: 145.00
Change: -0.20 (-0.14%)
Spread: 1.00 (0.694%)
Open: 150.00
High: 150.00
Low: 143.60
Prev. Close: 144.60
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First quarter trading update

30 Apr 2024 07:00

RNS Number : 4859M
Elementis PLC
30 April 2024
 

 

30 April 2024

 

Elementis plc

First quarter trading update

Sales and profit growth with margin improvement; CMD objectives on track.

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues its scheduled trading update for the three months ("the quarter") ended 31 March 2024.

Elementis will publish its interim results for the six months to 30 June 2024 on 1 August 2024.

 

Business performance

The Group delivered a good first quarter performance, with constant currency revenue up by 3%, adjusted operating profit up by double digits, and a material improvement in operating margin, compared to Q1 2023.

Personal Care sales in the quarter were broadly flat on the strong prior year period. We saw good growth in Cosmetics, offset by an expected slower start to the year in AP Actives due to order phasing.

Performance Specialties delivered an improved performance in the quarter, with sales and profit above a weak prior year period.

· Coatings sales increased low double-digit percentage versus the prior year period, benefiting from volume restocking and improved mix.

· Talc had a challenging quarter, impacted by the Finnish transport workers' union strike in early March, closing ports and stopping railway freight traffic for four weeks. This resulted in higher logistics costs and reduced sales in the quarter.

Cash generation in the first quarter was in line with expectations, with further reduction in inventory levels.

 

Outlook

The year has started well. Whilst we have not yet seen a positive step change in the demand environment, we remain confident about our ability to deliver profit growth and margin improvement in line with expectations1.

Implementation of the growth and efficiency programmes presented at the November 2023 Capital Markets Day ("CMD") is progressing well. Self help is critical in this, particularly the $30 million of cost savings commitment, and we are on-track to deliver $12 million this year and $18 million in 2025. In addition, we launched five new products and delivered $13 million of sales from new business in the first quarter, despite a continued challenging demand environment.

 

Paul Waterman, CEO of Elementis, said:

"Elementis has had a good start to the 2024 financial year, with our focus firmly on the execution of our CMD objectives. I am confident that our clear strategy focused on innovation, growth and efficiency will allow us to achieve a significant improvement in our full-year performance and continued margin expansion, in line with expectations1."

Note: 1. Based on company compiled consensus dated 25 April 2024, adjusted operating profit of $117 million and adjusted operating margin of 15.8% for the financial year 2024.

 

Enquiries

Investors: Eva Hatfield, Elementis plc Tel: +44 7553 340380

Press: Martin Robinson/Olivia Peters, Teneo Tel: +44 (0) 20 7353 4200

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKCBKOBKDQQB
Date   Source Headline
8th Mar 202210:39 amRNSDirector/PDMR Shareholding
7th Mar 20223:26 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSPreliminary results year ended 31 December 2021
1st Mar 20222:03 pmRNSDirector Declaration
1st Mar 202211:18 amRNSBlock listing Interim Review
18th Jan 20227:00 amRNSTrading Update
10th Jan 20221:20 pmRNSHolding(s) in Company
4th Jan 202211:48 amRNSTotal Voting Rights
1st Dec 202111:10 amRNSTotal Voting Rights
10th Nov 202112:20 pmRNSHolding(s) in Company
3rd Nov 202111:25 amRNSHolding(s) in Company
1st Nov 20211:44 pmRNSTotal Voting Rights
28th Oct 20217:00 amRNSQ3 Trading Update
19th Oct 20216:10 pmRNSDirector Declaration
5th Oct 20218:42 amRNSDirector Declaration
1st Sep 20219:49 amRNSBlock listing Interim Review
2nd Aug 202110:22 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSDirectorate Change
29th Jul 20217:00 amRNSHalf-year Report
5th Jul 202110:15 amRNSTotal Voting Rights
25th Jun 20212:59 pmRNSHolding(s) in Company
23rd Jun 20212:56 pmRNSDirector Declaration
1st Jun 202110:06 amRNSTotal Voting Rights
13th May 20213:39 pmRNSResult of AGM
13th May 20217:00 amRNSAGM Trading Statement
22nd Apr 20213:26 pmRNSAdditional Listing
20th Apr 20214:18 pmRNSResponse to Innospec Inc. announcement
20th Apr 20212:36 pmRNSPress Speculation Re Possible Offer for Elementis
9th Apr 20215:15 pmRNSAnnual Financial Report
7th Apr 20215:31 pmRNSDirector/PDMR Shareholding
1st Apr 20218:49 amRNSDirector/PDMR Shareholding
30th Mar 20214:08 pmRNSHolding(s) in Company
29th Mar 20214:46 pmRNSHolding(s) in Company
25th Mar 202112:36 pmRNSDirector/PDMR Shareholding
24th Mar 20213:24 pmRNSDirector/PDMR Shareholding
23rd Mar 20211:34 pmRNSDirector/PDMR Shareholding
23rd Mar 20217:00 amRNS2020 Preliminary Results Announcement
18th Mar 20217:07 amRNSDirector Declaration
11th Mar 20217:00 amRNS2020 Preliminary Results revised date
10th Mar 20214:26 pmRNSDirector/PDMR Shareholding
1st Mar 202112:00 pmRNSBlock listing Interim Review
14th Jan 20217:00 amRNSTrading update
15th Dec 202011:57 amRNSForm 8.5 (EPT/RI) - Elementis plc amendment
14th Dec 20202:11 pmRNSForm 8.3 - Elementis PLC
11th Dec 20203:20 pmRNSForm 8.3 - Elementis plc
11th Dec 20202:57 pmRNSForm 8.3 - Elementis plc
11th Dec 20201:54 pmRNSForm 8.3 - Elementis plc
11th Dec 202011:30 amBUSForm 8.3 - Elementis Plc
11th Dec 202011:10 amRNSForm 8.5 (EPT/RI) - Elementis plc
11th Dec 202011:09 amRNSForm 8.5 (EPT/NON-RI) - Elementis plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.